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Expression of Human Recombination Activating Genes (RAG-1 and RAG-2) in
Hodgkin's Disease There is now accumulating phenotypic and genotypic evidence that the putative tumor cells in Hodgkin's disease (HD), the Sternberg-Reed (SR) cells, are of lymphoid ~r i g i n .~-'~ However, the maturation status of the SR cells is still a matter of discussion, particularly whether they derive from immature lymphoid cells or from already primed (rearranged) B cells or T cell^.'^-^^ Because the assessment of RAG mRNA expression offers a new tool in the determination of the genotypic maturation status of lymphoid malignancies: we chose this approach in HD. Using a sensitive reverse transcription polymerase chain reaction (RT-PCR) we analyzed the RAG mRNA expression in 27 HD cases, including 6 cases with massive infiltration by SR cells. Furthermore, in positive cases and a T-ALL control case, RAG mRNA expression was quantitated by competitive PCR (C-PCR)."
MATERIALS AND METHODS
Tissue selection. Snap-frozen tissue samples from 11 diagnostic lymph node biopsies with numerous SR cells (six cases with > 25% SR cells, five cases with 10% to 25% SR cells), collected over a 9-year period and stored at -7O"C, were analyzed together with 16 randomly chosen HD cases showing few SR cells. Histologic classification, DNA rearrangement studies, and Epstein-Barr virus (EBV) DNA status of all but one case have recently been reported in this journal.'* Total cytoplasmic RNA was isolated from fresh frozen tissue by caesium chloride centrifugation according to Chirgwin et all9 with minor modifications." RNA solutions were adjusted to a concentration of 100 ng/pL in Tris-EDTA, 5 mmol/L, pH 7.5, and stored at -70°C until used.
RT-PCR was performed with the GeneAmp rTth reverse transcriptase RNA PCR Kit (Perkin Elmer Cetus, Norwalk, CT). The manufacturer's amplification protocol was applied with the following modifications: reverse transcription was per-RNA preparation. PCR primers. DM151, 5'-GTCTCTGAATCAGAAATCC-CTATC3', is identical to the IL-la 5' primer." HK31, 5'-GC-CATGAAGAGCAGTGAATTAJ', corresponds to the RAG-I sequences 2135 to 2155.2 HK28,5'-TTGGCATATACCAGGAGA-CAAT-3'. corresponds to the RAG-2 sequences 1141 to 1 160. 3 Specificity of the amplified products obtained with the HK31/32 set of primers was confirmed with a 32P-endlabeled internal probe, HK32 Hyb, extending from position 2450 to 2470 (5'-GAGACAGTCCCTTCCATAGAT-3') of the RAG-1 gene. The specific internal oligonucleotide probe for amplified RAG-2 sequences, HK29 Hyb (5'-GAGTCTTCAAAGG-GAGTGGA-3') extends from position 1297 to 1278 of the RAG-2 ~equence.~ Because this oligonucleotide sequence shows a complete homology between humans and mice5 it was also used as RT-PCR primer for a positive murine RAG-2 mRNA expression control. The concentration of the "ZP-endlabeled internal probes was 1 to 1.5 x lo6 cpm/mL hybridization solution. The specificity of the amplification products obtained with either the HK31/32 set of primers (RAG-1) or the HK28/29 set of primers (RAG-2) is shown in Fig 1. Positive controls for RAG mRNA expression were RNA from a human T-ALL differentiation stage I1 (TdT+, CDl+, CD2-, CD3-, CD4-, CD5+, CD7+, CD8-) and RNA from mouse thymus. To confirm that the positive results were caused by cDNA amplification, RNA samples of the controls were also assessed by PCR without prior reverse transcription. As negative controls for RAG mRNA expression we used RNA from two cases of hairy cell leukemia (HCL), from a case of diffuse lymph node hyperplasia (LN react) and from the Namalwa cell line (Nam). Quality control of target RNA samples was performed by successful RT-PCR with an HLA-DQa set of primers.
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The GeneAmp rTrh reverse transcriptase RNA PCR Kit contains a positive synthetic control RNA template transcribed from an insert in the plasmid PAW 109. Reverse transcription of a given quantity of control RNA template followed by cDNA PCR results in generation of a 308-bp amplification product whose amount is directly proportional to the quantity of input RNA.22 In our system with 50 amplification cycles, 10' copies of the synthetic control RNA template (called interleukin-1 [IL-I]) still yielded a clearly detectable 308-bp amplification product on gel electrophoresis (Fig 2) . However, the simultaneous amplification of this standard cDNA and target cDNA does not allow the determination of the approximate initial number of cDNA copies in the target sample because the amplification efficiency for each cDNA depends on the specific primer sequences and the length of the templates. 
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tube) with identical aliquots of the cDNA of interest. Because the ratio of products remains constant throughout amplification, equal input amounts of competitor DNA and target cDNA will yield equal amounts of amplification products. Digestion of the amplification products with a restriction enzyme specific for the competitor DNA near to its 5' or 3' end will generate two new fragments, one nearly as long as the undigestable cDNA product and one very short. Therefore, the gel electrophoretic profile of such a C-PCR series, after specific enzymatic digestion has occurred, allows easy identification of the titration point (ie, equal amounts of competitor DNA and target cDNA) at which the intensity of the cDNA band and the long band of competitor DNA are similar. In our study the RAG-1 primers (HK31 and HK32) used are identical for humans and mice. However, the 573-bp long RAG-1 target sequence (bp 2135 to 2707) has a 10% base sequence heterogeneity between humans and mice with two HindIII sites (positions 2250 and 2660) not present in humans2 Thus, HindIII digestion of mouse RAG-1 target sequences produces three fragments of 440, 116, and 47 bp, respectively.
We performed C-PCR in our RAG-1-positive cases with mouse genomic DNA as a competitor. Titration series of the competitor DNA were prepared at dilutions ranging from lo6 to 4 x 10' RAG-1 templates per 10 p L stock solution.
Reverse transcription of 1.2 pg RNA was performed in a total volume of 60 pL at conditions as described above. Subsequently, 5 pL of this cDNA solution was aliquoted in 12 tubes each containing 10 pL of competitor DNA from the stock dilution series. C-PCR was performed in a 50 pL reaction containing 0.5 pmol/L each of two oligonucleotide primers, 400 pmol/L of each dNTP, 10 mmol/L KCI, 10 mmol/L Tris-HCI, pH 8.3,4 mmol/L MgC12 and 5 U Ampli Tuq Stoffel fragment DNA polymerase (Perkin Elmer Cetus). Thirty-five cycles were routinely performed. In all titration series 15 pL of each sample were electrophoresed without prior digestion, and 10 pL of each sample were digested with HindIII in a total volume of 20 pL and electrophoresed (see also Fig 4) .
RESULTS
The pattern of RAG expression in controls and HD cases is summarized in Table 1 . The highest level of RAG-1 mRNA was observed in mouse thymus and the human T-ALL case. In HD, only one case (with few SR cells) showed significant RAG-1 mRNA expression (Fig 3) . Interestingly, this EBV DNA-positive case had a clonal rearrangement for A light chain.ls In this case and in the T-ALL control RAG-1 mRNA expression was quantitated by C-PCR. As shown in Fig 4 the T-ALL case had > lo5 specific cDNA templates transcribed per microgram RNA, the HD case had about 104. All other HD cases, including those with numerous SR cells, lacked significant RAG expression. The mature B-cell line Nam, reported to be negative for RAG-1 expression when analyzed by Northern blotting,2 showed a weak RAG-1 expression (Table 1) ; this expression was still stronger than that identified in one HD case with abundant SR cells (Fig 5) . In this case and in Nam cells transcription of RAG-1 mRNA was < 2 x lo3 templates per microgram RNA as determined by C-PCR. In the six cases with abundant SR cells there was no correlation between RAG expression or Ig or TCR gene rearrangement and EBV DNA status: one case had no detectable EBV DNA, but clonal rearrangement for JH; five cases were without clonal rearrangements, three with only a few EBV genomes (I lo2) and two with numerous viral copies In our RT-PCR system RAG-2 expression was not observed at all in HD.
DISCUSSION
The results of this study indicate that RAG-1 and RAG-2 are typically not expressed in HD. We found that cases with massive infiltration by SR cells (> 25%), when assessed with a very sensitive RT-PCR method, lacked RAG expression or showed expression levels inferior or equal to those of the negative controls. We conclude that RAG-1 and RAG-2 expression is very low or absent in SR cells.
As shown by Northern blot analysis RAG-1 and RAG-2 are synergistically expressed in pre-B-and pre-T-cell lines, but not in mature B-and T-cell Coexpression of RAG-1 and RAG-2 is also observed in cortical thymocytes during productive TCR rearrangement, but is downregulated in medullary thymocytes; RAG expression is terminated when double-positive thymocytes (CD4+,CD8+) undergo positive selection into single-positive cells (CD4+ or CD8+) through interaction of their TCR with the major histocompatibility ~o m p l e x .~ Analyzing a large series of acute leukemias with a sensitive RT-PCR method, Bories et a15 recently reported strong RAG expression in T-ALL and pre-B-ALL. However, no RAG expression was observed in slg+ ALL (Burkitt's type), chronic lymphocytic leukemia (B-CLL), and nodular lymphomas. These data suggest that RAG expression is a highly specific marker of the genotypic maturation status of both B and T cells. use only.
For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From rearrangement machinery could be identified; (3) in three further cases, all nonclonal, with massive infiltration by SR cells ( > l o 4 per kg DNA), EBV genomes were scarce ( I loz per kg DNA) and therefore very unlikely to be a transforming element interacting with Ig gene rearrangement. In such cases outgrowth of clonal SR populations has been reported with disease progression.' In the light of our findings this is best explained by initially mature oligoclonal/ polyclonal (rearranged) SR populations with subsequent growth advantage of one clone. Lack of RAG expression in SR cells is also consistent with a very early B-cell genotype before recombinase activation as observed in the LyD9 cell line.3 However, it is quite unlikely that SR cells belong to this cell type because a characteristic SR cell marker (Ki-1) is not identified in fetal bone marrow and liver14 known to harbor such early lymphoid progenitors. The very low RAG expression identified in some cases (as little or less than that observed in the negative controls) probably results from illegitimate transcriptionz7 and minimal DNA contamination. However, very low copy numbers of RAG mRNA could result either from the presence of single cells with a high RAG expression or from very few cells with low RAG expression. Recently, for example, it has been shown in mice that RAG expression is also observed in a very small population of mature, slgM-positive B cells (<0.1% of bone marrow cells).28 One case, characterized by a few SR cells, A light chain gene rearrangement and significant RAG-1 expression remains unexplained. We have no means of detecting whether RAG transcription truly occurred in clonally rearranging SR cells, or if it was related to an early lymphoid clone unrelated to SR cells. In this case and the case with weak RAG expression the origin of the transcripts could be localized by in situ hybridization studies.
In summary, our study suggests that SR cells are derived from lymphoid cells beyond the pre-B or common thymocyte stage. It represents a novel approach in the characterization of the SR cells and should incite further analysis of HD cases with numerous SR cells and uncommon genotype.
